Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans

Abstract β2‐microglobulin (β2‐m) is a plasma protein derived from physiological shedding of the class I major histocompatibility complex (MHCI), causing human systemic amyloidosis either due to persistently high concentrations of the wild‐type (WT) protein in hemodialyzed patients, or in presence of...

Full description

Bibliographic Details
Main Authors: Sara Raimondi, Giulia Faravelli, Paola Nocerino, Valentina Mondani, Alma Baruffaldi, Loredana Marchese, Maria Chiara Mimmi, Diana Canetti, Guglielmo Verona, Marianna Caterino, Margherita Ruoppolo, P. Patrizia Mangione, Vittorio Bellotti, Francesca Lavatelli, Sofia Giorgetti
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:FASEB BioAdvances
Subjects:
Online Access:https://doi.org/10.1096/fba.2023-00073
_version_ 1797635965644177408
author Sara Raimondi
Giulia Faravelli
Paola Nocerino
Valentina Mondani
Alma Baruffaldi
Loredana Marchese
Maria Chiara Mimmi
Diana Canetti
Guglielmo Verona
Marianna Caterino
Margherita Ruoppolo
P. Patrizia Mangione
Vittorio Bellotti
Francesca Lavatelli
Sofia Giorgetti
author_facet Sara Raimondi
Giulia Faravelli
Paola Nocerino
Valentina Mondani
Alma Baruffaldi
Loredana Marchese
Maria Chiara Mimmi
Diana Canetti
Guglielmo Verona
Marianna Caterino
Margherita Ruoppolo
P. Patrizia Mangione
Vittorio Bellotti
Francesca Lavatelli
Sofia Giorgetti
author_sort Sara Raimondi
collection DOAJ
description Abstract β2‐microglobulin (β2‐m) is a plasma protein derived from physiological shedding of the class I major histocompatibility complex (MHCI), causing human systemic amyloidosis either due to persistently high concentrations of the wild‐type (WT) protein in hemodialyzed patients, or in presence of mutations, such as D76N β2‐m, which favor protein deposition in the adulthood, despite normal plasma levels. Here we describe a new transgenic Caenorhabditis elegans (C. elegans) strain expressing human WT β2‐m at high concentrations, mimicking the condition that underlies dialysis‐related amyloidosis (DRA) and we compare it to a previously established strain expressing the highly amyloidogenic D76N β2‐m at lower concentrations. Both strains exhibit behavioral defects, the severity of which correlates with β2‐m levels rather than with the presence of mutations, being more pronounced in WT β2‐m worms. β2‐m expression also has a deep impact on the nematodes' proteomic and metabolic profiles. Most significantly affected processes include protein degradation and stress response, amino acids metabolism, and bioenergetics. Molecular alterations are more pronounced in worms expressing WT β2‐m at high concentration compared to D76N β2‐m worms. Altogether, these data show that β2‐m is a proteotoxic protein in vivo also in its wild‐type form, and that concentration plays a key role in modulating pathogenicity. Our transgenic nematodes recapitulate the distinctive features subtending DRA compared to hereditary β2‐m amyloidosis (high levels of non‐mutated β2‐m vs. normal levels of variant β2‐m) and provide important clues on the molecular bases of these human diseases.
first_indexed 2024-03-11T12:28:05Z
format Article
id doaj.art-5149cb901be64b8ea5200c5f776cb102
institution Directory Open Access Journal
issn 2573-9832
language English
last_indexed 2024-03-11T12:28:05Z
publishDate 2023-11-01
publisher Wiley
record_format Article
series FASEB BioAdvances
spelling doaj.art-5149cb901be64b8ea5200c5f776cb1022023-11-06T06:21:11ZengWileyFASEB BioAdvances2573-98322023-11-0151148450510.1096/fba.2023-00073Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegansSara Raimondi0Giulia Faravelli1Paola Nocerino2Valentina Mondani3Alma Baruffaldi4Loredana Marchese5Maria Chiara Mimmi6Diana Canetti7Guglielmo Verona8Marianna Caterino9Margherita Ruoppolo10P. Patrizia Mangione11Vittorio Bellotti12Francesca Lavatelli13Sofia Giorgetti14Department of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyCentre for Amyloidosis, Division of Medicine University College London London UKDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyDepartment of Molecular Medicine and Medical Biotechnology University of Naples "Federico II" Naples ItalyDepartment of Molecular Medicine and Medical Biotechnology University of Naples "Federico II" Naples ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyResearch Department Fondazione IRCCS Policlinico San Matteo Pavia ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyDepartment of Molecular Medicine, Institute of Biochemistry University of Pavia Pavia ItalyAbstract β2‐microglobulin (β2‐m) is a plasma protein derived from physiological shedding of the class I major histocompatibility complex (MHCI), causing human systemic amyloidosis either due to persistently high concentrations of the wild‐type (WT) protein in hemodialyzed patients, or in presence of mutations, such as D76N β2‐m, which favor protein deposition in the adulthood, despite normal plasma levels. Here we describe a new transgenic Caenorhabditis elegans (C. elegans) strain expressing human WT β2‐m at high concentrations, mimicking the condition that underlies dialysis‐related amyloidosis (DRA) and we compare it to a previously established strain expressing the highly amyloidogenic D76N β2‐m at lower concentrations. Both strains exhibit behavioral defects, the severity of which correlates with β2‐m levels rather than with the presence of mutations, being more pronounced in WT β2‐m worms. β2‐m expression also has a deep impact on the nematodes' proteomic and metabolic profiles. Most significantly affected processes include protein degradation and stress response, amino acids metabolism, and bioenergetics. Molecular alterations are more pronounced in worms expressing WT β2‐m at high concentration compared to D76N β2‐m worms. Altogether, these data show that β2‐m is a proteotoxic protein in vivo also in its wild‐type form, and that concentration plays a key role in modulating pathogenicity. Our transgenic nematodes recapitulate the distinctive features subtending DRA compared to hereditary β2‐m amyloidosis (high levels of non‐mutated β2‐m vs. normal levels of variant β2‐m) and provide important clues on the molecular bases of these human diseases.https://doi.org/10.1096/fba.2023-00073C. elegansintegrated omicsmisfoldingproteotoxicitysystemic amyloidosisβ2‐microglobulin
spellingShingle Sara Raimondi
Giulia Faravelli
Paola Nocerino
Valentina Mondani
Alma Baruffaldi
Loredana Marchese
Maria Chiara Mimmi
Diana Canetti
Guglielmo Verona
Marianna Caterino
Margherita Ruoppolo
P. Patrizia Mangione
Vittorio Bellotti
Francesca Lavatelli
Sofia Giorgetti
Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans
FASEB BioAdvances
C. elegans
integrated omics
misfolding
proteotoxicity
systemic amyloidosis
β2‐microglobulin
title Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans
title_full Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans
title_fullStr Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans
title_full_unstemmed Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans
title_short Human wild‐type and D76N β2‐microglobulin variants are significant proteotoxic and metabolic stressors for transgenic C. elegans
title_sort human wild type and d76n β2 microglobulin variants are significant proteotoxic and metabolic stressors for transgenic c elegans
topic C. elegans
integrated omics
misfolding
proteotoxicity
systemic amyloidosis
β2‐microglobulin
url https://doi.org/10.1096/fba.2023-00073
work_keys_str_mv AT sararaimondi humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT giuliafaravelli humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT paolanocerino humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT valentinamondani humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT almabaruffaldi humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT loredanamarchese humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT mariachiaramimmi humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT dianacanetti humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT guglielmoverona humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT mariannacaterino humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT margheritaruoppolo humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT ppatriziamangione humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT vittoriobellotti humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT francescalavatelli humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans
AT sofiagiorgetti humanwildtypeandd76nb2microglobulinvariantsaresignificantproteotoxicandmetabolicstressorsfortransgeniccelegans